JAMA and JAMA Internal Medicine report that at 245 dollars per month, the CMS BALANCE model could save Medicare about 933 million dollars on semaglutide in 2027 and expand obesity coverage to more beneficiaries.
At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.
At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.
From @JAMA_current: At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare